2-Azaspiro[3.3]heptane Hydrochloride - CAS 1420271-08-4
Catalog: |
BB061549 |
Product Name: |
2-Azaspiro[3.3]heptane Hydrochloride |
CAS: |
1420271-08-4 |
Synonyms: |
2-azaspiro[3.3]heptane hydrochloride; 2-AZASPIRO[3.3]HEPTANE HCL; 2-azaspiro[3.3]heptane; hydrochloride; 2-Azaspiro[3.3]heptane-HCl; 2-azaspiro[3.3]heptanehydrochloride |
IUPAC Name: | 2-azaspiro[3.3]heptanehydrochloride |
Description: | 2-Azaspiro[3.3]heptane Hydrochloride may be useful in the preparation of N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides for treating or preventing FAP-mediated conditions. |
Molecular Weight: | 133.61 |
Molecular Formula: | C6H11N·HCl |
Canonical SMILES: | C1CC2(C1)CNC2.Cl |
InChI: | InChI=1S/C6H11N.ClH/c1-2-6(3-1)4-7-5-6/h7H,1-5H21H |
InChI Key: | OOGSZIVCFBCPFX-UHFFFAOYSA-N |
References: | Braanalt, J., et al. PCT Int. Appl., 566pp., WO 2022130270 (2022). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112920103-A | Method for mild preparation of 2-azaspiro [3.3] heptane hydrochloride | 20210302 |
CN-112778294-A | 5-aminoisoxazole derivative and application thereof in preparation of multi-kinase inhibitor | 20210107 |
CN-113321645-A | 5-aminoisoxazole derivative and application thereof in preparation of multi-kinase inhibitor | 20210107 |
US-2022048909-A1 | Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof | 20200814 |
WO-2022034529-A1 | Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof | 20200814 |
WO-2021142144-A1 | Mek inhibitors and therapeutic uses thereof | 20200110 |
WO-2021111124-A1 | Polyheterocyclic compounds as mettl3 inhibitors | 20191202 |
WO-2020074442-A1 | Phenyltetrazole derivatives as plasma kallikrein inhibitors | 20181010 |
EP-3863713-A1 | Phenyltetrazole derivatives as plasma kallikrein inhibitors | 20181010 |
JP-2022502461-A | Phenyltetrazole derivative as a plasma kallikrein inhibitor | 20181010 |
Complexity: | 78.2 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 133.0658271 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 133.0658271 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 12Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS